⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19687629 | 0.79 | SSTR4 (0.36) | — | |
| SCHEMBL21207668 | 0.79 | CNR2 (0.39) | — | |
| SCHEMBL21207697 | 0.74 | SSTR4 (0.39) | — | |
| SCHEMBL22548076 | 0.74 | SSTR4 (0.36) | — | |
| SCHEMBL16309058 | 0.73 | UHRF1 (0.35) | — | |
| SCHEMBL19687627 | 0.72 | SSTR4 (0.37) | — | |
| SCHEMBL21719512 | 0.72 | CNR2 (0.33) | — | |
| SCHEMBL25825965 | 0.71 | KDM4E (0.31) | — | |
| SCHEMBL24910863 | 0.71 | CNR2 (0.33) | — | |
| SCHEMBL22624047 | 0.71 | LATS1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10220036-B2 | Triazolopyrimidine compounds and uses thereof | NOVARTIS AG (CH) | 2019-03-05 | — | — | US | disclosed |
| US-20170348312-A1 | TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. | 2017-12-07 | — | — | US | disclosed |